Bio-Techne Quarterly Balance Sheets Chart
Quarterly
|
Annual
Bio-Techne Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2016-09-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 162,186,000 | 140,670,000 | 177,549,000 | 187,540,000 | 151,791,000 | 139,915,000 | 130,132,000 | 148,663,000 | 180,571,000 | 127,282,000 | 164,682,000 | 165,257,000 | 172,567,000 | 160,821,000 | 211,845,000 | 196,321,000 | 199,091,000 | 186,136,000 | 165,526,000 | 169,404,000 | 146,625,000 | 156,216,000 | 110,293,000 | 99,891,000 | 100,886,000 | 95,561,000 | 85,886,000 | 94,674,000 | 121,990,000 | 86,608,000 | 121,458,000 | 69,589,000 | 65,713,000 | 62,452,000 | 48,842,000 | 54,532,000 | 106,447,000 | 98,239,000 | 318,568,000 | 123,603,000 | 98,402,000 | 83,856,000 | 163,786,000 | 150,713,000 | 143,286,000 | 130,805,000 | 116,675,000 | 95,280,000 | 80,994,000 | 79,235,000 | 77,613,000 |
| short-term available-for-sale investments | 1,072,000 | 5,397,000 | 5,520,000 | 23,739,000 | 29,915,000 | 32,074,000 | 37,818,000 | 74,462,000 | 70,351,000 | 67,135,000 | 38,740,000 | 32,463,000 | 90,108,000 | 117,426,000 | 117,986,000 | 124,268,000 | 104,872,000 | 133,657,000 | 58,520,000 | 65,147,000 | 83,229,000 | 70,647,000 | 69,047,000 | 59,764,000 | 89,826,000 | 40,927,000 | 52,381,000 | 18,874,000 | 51,471,000 | 38,423,000 | 56,389,000 | 53,503,000 | 32,573,000 | 44,786,000 | 96,528,000 | 88,454,000 | 100,843,000 | 169,151,000 | 162,162,000 | 142,809,000 | 142,262,000 | 152,311,000 | 124,325,000 | 56,758,000 | 54,120,000 | 63,200,000 | |||||
| accounts receivable, less allowances | 206,876,000 | 237,140,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| inventories | 189,446,000 | 191,083,000 | 188,373,000 | 185,041,000 | 179,731,000 | 179,496,000 | 180,839,000 | 186,080,000 | 171,638,000 | 169,464,000 | 160,233,000 | 150,009,000 | 141,123,000 | 128,283,000 | 121,858,000 | 117,366,000 | 116,748,000 | 109,990,000 | 106,590,000 | 106,003,000 | 103,152,000 | 99,673,000 | 95,351,000 | 90,855,000 | 91,050,000 | 93,839,000 | 90,905,000 | 90,918,000 | 85,648,000 | 88,586,000 | 68,280,000 | 70,519,000 | 57,066,000 | 58,675,000 | 58,967,000 | 49,577,000 | 51,045,000 | 52,195,000 | 38,847,000 | 38,386,000 | 39,992,000 | 39,957,000 | 34,877,000 | 35,675,000 | 37,600,000 | 38,397,000 | 38,277,000 | 40,497,000 | 40,978,000 | 42,116,000 | 44,906,000 |
| current assets held-for-sale | 12,332,000 | 4,700,000 | 1,047,000 | 9,459,000 | 9,773,000 | 26,669,000 | 26,647,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other current assets | 37,460,000 | 53,647,000 | 49,731,000 | 42,839,000 | 33,658,000 | 31,286,000 | 40,051,000 | 52,164,000 | 27,066,000 | 27,920,000 | 23,431,000 | 24,773,000 | 22,856,000 | 31,558,000 | 36,496,000 | 43,773,000 | 16,919,000 | 22,582,000 | 24,148,000 | 25,865,000 | 24,341,000 | 13,715,000 | 14,020,000 | 19,955,000 | 18,058,000 | 16,877,000 | 19,213,000 | 13,720,000 | 10,668,000 | 6,240,000 | |||||||||||||||||||||
| total current assets | 608,300,000 | 627,240,000 | 634,640,000 | 648,567,000 | 617,419,000 | 610,650,000 | 590,640,000 | 591,477,000 | 621,482,000 | 570,996,000 | 565,183,000 | 552,031,000 | 605,556,000 | 593,108,000 | 590,230,000 | 543,748,000 | 510,606,000 | 566,606,000 | 541,933,000 | 541,893,000 | 520,920,000 | 491,928,000 | 465,074,000 | 391,945,000 | 412,607,000 | 423,433,000 | 379,934,000 | 383,112,000 | 398,366,000 | 393,504,000 | 346,086,000 | 310,151,000 | 236,739,000 | 258,383,000 | 240,997,000 | 248,283,000 | 294,738,000 | 268,111,000 | 469,413,000 | 319,531,000 | 279,141,000 | 280,636,000 | 409,516,000 | 390,157,000 | 359,731,000 | 350,143,000 | 346,507,000 | 306,272,000 | 227,216,000 | 219,010,000 | 230,417,000 |
| | |||||||||||||||||||||||||||||||||||||||||||||||||||
| property and equipment | 245,719,000 | 251,977,000 | 249,753,000 | 253,939,000 | 251,154,000 | 243,728,000 | 234,204,000 | 231,683,000 | 226,200,000 | 223,571,000 | 223,851,000 | 224,098,000 | 223,242,000 | 218,398,000 | 211,814,000 | 207,134,000 | 207,907,000 | 198,975,000 | 195,602,000 | 191,677,000 | 176,829,000 | 165,012,000 | 164,313,000 | 156,783,000 | 154,039,000 | 145,319,000 | 145,262,000 | 146,511,000 | 145,348,000 | 142,779,000 | 138,461,000 | 133,805,000 | 133,666,000 | 134,043,000 | 132,852,000 | 129,749,000 | 124,485,000 | 122,006,000 | 117,120,000 | 116,649,000 | 115,159,000 | 113,362,000 | 108,756,000 | 105,202,000 | 101,133,000 | 94,920,000 | 93,788,000 | 94,614,000 | 94,604,000 | 94,352,000 | 95,398,000 |
| right-of-use assets | 73,399,000 | 83,744,000 | 85,383,000 | 89,221,000 | 91,285,000 | 97,258,000 | 100,863,000 | ||||||||||||||||||||||||||||||||||||||||||||
| goodwill | 980,935,000 | 968,612,000 | 964,607,000 | 982,585,000 | 972,663,000 | 970,966,000 | 980,082,000 | 969,376,000 | 872,737,000 | 870,542,000 | 869,589,000 | 865,418,000 | 822,101,000 | 827,618,000 | 832,056,000 | 840,020,000 | 843,067,000 | 746,460,000 | 746,666,000 | 731,636,000 | 728,308,000 | 725,831,000 | 734,241,000 | 730,412,000 | 732,667,000 | 719,608,000 | 706,355,000 | 704,790,000 | 597,890,000 | 610,667,000 | 589,101,000 | 565,789,000 | 434,734,000 | 423,895,000 | 427,317,000 | 390,638,000 | 385,831,000 | 305,234,000 | 151,473,000 | 144,654,000 | 144,361,000 | 143,800,000 | 84,336,000 | 84,311,000 | 87,166,000 | 86,936,000 | 85,682,000 | 86,524,000 | 85,240,000 | 85,360,000 | 86,633,000 |
| intangible assets | 365,599,000 | 443,699,000 | 461,051,000 | 486,004,000 | 507,081,000 | 526,428,000 | 550,605,000 | 578,971,000 | 534,645,000 | 553,257,000 | 567,647,000 | 585,534,000 | 531,522,000 | 551,342,000 | 569,347,000 | 596,300,000 | 615,968,000 | 489,178,000 | 504,172,000 | 507,591,000 | 516,545,000 | 530,333,000 | 549,712,000 | 563,338,000 | 579,429,000 | 579,142,000 | 608,273,000 | 632,686,000 | 446,332,000 | 443,794,000 | 438,360,000 | 503,626,000 | 315,310,000 | 315,547,000 | 325,396,000 | 292,839,000 | 297,313,000 | 307,508,000 | 108,776,000 | 96,110,000 | 98,546,000 | 100,523,000 | 40,552,000 | 41,779,000 | 44,938,000 | 46,073,000 | 46,476,000 | 48,352,000 | 48,679,000 | 50,030,000 | 52,282,000 |
| deferred tax asset | 10,307,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 273,609,000 | 268,987,000 | 274,990,000 | 275,701,000 | 264,265,000 | 272,140,000 | 274,359,000 | 281,576,000 | 285,302,000 | 283,354,000 | 53,194,000 | 53,895,000 | 46,828,000 | 45,976,000 | 37,106,000 | 11,589,000 | 11,575,000 | 11,593,000 | 11,339,000 | 10,281,000 | 13,522,000 | 12,167,000 | 9,251,000 | 5,588,000 | 5,668,000 | 5,116,000 | 5,008,000 | 5,099,000 | 5,266,000 | 27,064,000 | 43,414,000 | 4,106,000 | 1,474,000 | 1,585,000 | 1,757,000 | 1,851,000 | 1,938,000 | 1,826,000 | 1,688,000 | 2,265,000 | 2,368,000 | 2,492,000 | 2,031,000 | 3,076,000 | 3,033,000 | 2,844,000 | 1,849,000 | 1,621,000 | 1,219,000 | 11,300,000 | 1,319,000 |
| total assets | 2,557,868,000 | 2,644,259,000 | 2,670,424,000 | 2,736,017,000 | 2,703,867,000 | 2,721,170,000 | 2,730,753,000 | 2,755,360,000 | 2,638,692,000 | 2,599,696,000 | 2,363,401,000 | 2,350,721,000 | 2,294,805,000 | 2,299,892,000 | 2,304,846,000 | 2,270,187,000 | 2,262,957,000 | 2,084,642,000 | 2,067,866,000 | 2,053,096,000 | 2,027,589,000 | 1,999,022,000 | 1,998,415,000 | 1,925,028,000 | 1,884,410,000 | 1,872,618,000 | 1,844,832,000 | 1,872,198,000 | 1,593,202,000 | 1,617,808,000 | 1,555,422,000 | 1,121,924,000 | 1,133,453,000 | ||||||||||||||||||
| liabilities and shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts payable | 25,311,000 | 31,644,000 | 33,120,000 | 31,559,000 | 37,968,000 | 28,895,000 | 31,514,000 | 28,084,000 | 25,679,000 | 27,120,000 | 24,100,000 | 30,475,000 | 33,865,000 | 30,859,000 | 26,756,000 | 25,621,000 | 29,384,000 | 25,842,000 | 24,252,000 | 27,190,000 | 23,090,000 | 19,735,000 | 19,092,000 | 14,106,000 | 16,210,000 | 14,898,000 | 16,013,000 | 18,259,000 | 18,452,000 | 14,530,000 | 11,318,000 | 14,178,000 | 13,516,000 | 10,426,000 | 13,177,000 | 13,443,000 | 13,510,000 | 13,571,000 | 9,652,000 | 8,418,000 | 7,163,000 | 6,656,000 | 6,236,000 | 6,189,000 | 6,466,000 | 6,541,000 | 6,291,000 | 6,451,000 | 5,914,000 | 5,734,000 | 5,207,000 |
| salaries, wages and related accruals | 65,791,000 | 61,896,000 | 53,594,000 | 41,977,000 | 49,818,000 | 44,313,000 | 32,995,000 | 34,891,000 | 36,747,000 | 38,518,000 | 28,633,000 | 32,557,000 | 61,953,000 | 55,642,000 | 43,921,000 | 32,213,000 | 51,294,000 | 43,268,000 | 31,907,000 | 21,805,000 | 31,087,000 | 23,426,000 | 18,612,000 | 17,543,000 | 28,638,000 | 23,523,000 | 19,677,000 | 15,180,000 | 23,710,000 | 19,839,000 | 26,537,000 | 10,110,000 | 13,100,000 | 10,130,000 | 9,134,000 | 10,344,000 | 9,281,000 | 9,869,000 | 6,158,000 | 6,462,000 | 5,174,000 | 6,409,000 | 4,025,000 | 4,610,000 | 3,611,000 | 4,536,000 | 4,699,000 | 5,377,000 | 3,764,000 | 4,864,000 | 4,784,000 |
| accrued expenses | 25,663,000 | 23,905,000 | 27,543,000 | 21,088,000 | 24,886,000 | 17,806,000 | 17,159,000 | 15,937,000 | 14,880,000 | 15,641,000 | 16,279,000 | 13,790,000 | 17,886,000 | 19,998,000 | 18,991,000 | 17,419,000 | 15,282,000 | 15,689,000 | 13,973,000 | 13,004,000 | 9,093,000 | 9,696,000 | 10,736,000 | 11,048,000 | 26,389,000 | 28,296,000 | 25,862,000 | 23,509,000 | 21,403,000 | 18,767,000 | 14,508,000 | 19,967,000 | 7,021,000 | 7,493,000 | 6,537,000 | 6,604,000 | 7,208,000 | 6,709,000 | 4,136,000 | 3,806,000 | 7,954,000 | 4,242,000 | 9,603,000 | 7,438,000 | 4,693,000 | 3,101,000 | 7,275,000 | 10,152,000 | 3,478,000 | 11,680,000 | |
| contract liabilities | 32,571,000 | 32,269,000 | 27,715,000 | 26,614,000 | 27,930,000 | 30,108,000 | 28,427,000 | 24,516,000 | 23,069,000 | 24,878,000 | 21,812,000 | 22,059,000 | 23,406,000 | 23,107,000 | 19,081,000 | 19,121,000 | 18,995,000 | 18,714,000 | 13,217,000 | 13,285,000 | 13,049,000 | 13,556,000 | 11,893,000 | 9,108,000 | 9,084,000 | 10,112,000 | 8,396,000 | 8,762,000 | |||||||||||||||||||||||
| income taxes payable | 10,770,000 | 3,628,000 | 3,141,000 | 3,136,000 | 3,706,000 | 12,082,000 | 6,646,000 | 5,938,000 | 12,022,000 | 18,168,000 | 25,277,000 | 17,270,000 | 13,237,000 | 9,788,000 | 14,284,000 | 6,505,000 | 5,336,000 | 3,562,000 | 3,658,000 | 2,157,000 | 2,376,000 | 10,378,000 | 12,851,000 | 6,533,000 | 5,764,000 | 5,318,000 | 4,984,000 | 5,232,000 | 8,878,000 | 6,412,000 | 4,646,000 | 3,953,000 | 852,000 | 8,444,000 | 1,972,000 | 2,019,000 | 1,975,000 | 496,000 | 5,678,000 | 1,818,000 | 2,969,000 | 2,276,000 | 4,176,000 | 2,284,000 | 2,553,000 | 3,251,000 | 4,477,000 | 967,000 | 3,958,000 | 5,509,000 | |
| operating lease liabilities - current | 14,098,000 | 14,049,000 | 13,511,000 | 13,485,000 | 12,920,000 | 12,978,000 | 12,672,000 | 12,198,000 | 11,199,000 | 10,723,000 | 10,975,000 | 12,115,000 | 11,928,000 | 11,864,000 | 11,809,000 | 12,001,000 | 11,602,000 | 10,414,000 | 9,912,000 | 9,695,000 | 9,535,000 | 9,544,000 | 9,398,000 | 9,260,000 | |||||||||||||||||||||||||||
| other current liabilities | 1,645,000 | 1,813,000 | 2,632,000 | 4,269,000 | 2,151,000 | 2,949,000 | 4,225,000 | 4,440,000 | 1,413,000 | 865,000 | 1,319,000 | 1,963,000 | 1,243,000 | 3,080,000 | 5,467,000 | 3,612,000 | 3,891,000 | 2,581,000 | 3,166,000 | ||||||||||||||||||||||||||||||||
| total current liabilities | 175,849,000 | 169,204,000 | 161,256,000 | 142,128,000 | 159,379,000 | 149,820,000 | 135,231,000 | 127,754,000 | 128,509,000 | 141,163,000 | 128,395,000 | 137,629,000 | 176,018,000 | 166,838,000 | 154,809,000 | 133,992,000 | 152,284,000 | 137,640,000 | 117,568,000 | 105,424,000 | 106,668,000 | 104,985,000 | 104,953,000 | 88,268,000 | 101,985,000 | 98,047,000 | 87,432,000 | 83,442,000 | 79,510,000 | 70,889,000 | 111,679,000 | 107,016,000 | 46,616,000 | 35,829,000 | 45,040,000 | 39,768,000 | 38,513,000 | 40,618,000 | 26,391,000 | 24,364,000 | 22,109,000 | 20,276,000 | 32,084,000 | 32,481,000 | 21,268,000 | 22,901,000 | 35,750,000 | 30,721,000 | 14,123,000 | 26,236,000 | 18,188,000 |
| deferred income taxes | 6,169,000 | 31,924,000 | 37,723,000 | 50,017,000 | 55,863,000 | 63,666,000 | 71,575,000 | 83,134,000 | 88,982,000 | 94,607,000 | 111,381,000 | 112,920,000 | 98,994,000 | 99,301,000 | 101,423,000 | 98,812,000 | 93,125,000 | 98,401,000 | 105,342,000 | 101,374,000 | 101,090,000 | 96,178,000 | 104,579,000 | 88,530,000 | 89,754,000 | 96,844,000 | 104,113,000 | 113,843,000 | 86,293,000 | 86,987,000 | 74,103,000 | 135,512,000 | 61,373,000 | 11,513,000 | 16,677,000 | 11,511,000 | 11,729,000 | 19,148,000 | 9,623,000 | 8,509,000 | 9,878,000 | 9,527,000 | 9,944,000 | 10,068,000 | 4,214,000 | 6,170,000 | 14,234,000 | 4,264,000 | 12,921,000 | 6,730,000 | 5,797,000 |
| long-term debt obligations | 346,000,000 | 330,000,000 | 300,000,000 | 300,000,000 | 319,000,000 | 389,000,000 | 447,000,000 | 440,000,000 | 350,000,000 | 370,000,000 | 200,000,000 | 264,661,000 | 243,410,000 | 246,514,000 | 269,618,000 | 287,723,000 | 328,827,000 | 202,931,000 | 219,035,000 | 311,139,000 | 344,243,000 | 407,348,000 | 370,452,000 | 473,556,000 | 492,660,000 | 339,000,000 | 392,500,000 | 362,500,000 | 343,500,000 | 157,808,000 | 162,789,000 | 164,368,000 | 73,000,000 | 144,000,000 | 112,000,000 | ||||||||||||||||
| operating lease liabilities | 83,960,000 | 79,450,000 | 81,616,000 | 85,433,000 | 87,618,000 | 92,752,000 | 96,027,000 | 97,332,000 | 93,766,000 | 93,267,000 | 78,183,000 | 64,756,000 | 58,133,000 | 56,348,000 | 57,718,000 | 65,059,000 | 67,625,000 | 66,816,000 | 63,672,000 | 65,694,000 | 67,248,000 | 69,491,000 | 71,693,000 | 72,870,000 | |||||||||||||||||||||||||||
| other long-term liabilities | 27,082,000 | 15,656,000 | 11,337,000 | 19,789,000 | 13,157,000 | 11,557,000 | 17,361,000 | 9,394,000 | 10,919,000 | 10,973,000 | 11,336,000 | 11,501,000 | 12,239,000 | 12,769,000 | 11,747,000 | 20,046,000 | 24,462,000 | 23,812,000 | 25,796,000 | 29,981,000 | 26,949,000 | 28,052,000 | 20,706,000 | 22,450,000 | 25,222,000 | 19,496,000 | 17,993,000 | 9,671,000 | 9,338,000 | 9,140,000 | 9,321,000 | 3,654,000 | 3,164,000 | 3,220,000 | 3,146,000 | 3,204,000 | 2,144,000 | 708,000 | |||||||||||||
| shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 1,550,000 | 1,568,000 | 1,579,000 | 1,589,000 | 1,582,000 | 1,576,000 | 1,571,000 | 1,584,000 | 1,576,000 | 1,573,000 | 1,571,000 | 392,000 | 392,000 | 393,000 | 393,000 | 393,000 | 390,000 | 389,000 | 388,000 | 386,000 | 385,000 | 381,000 | 383,000 | 381,000 | 379,000 | 378,000 | 377,000 | 378,000 | 376,000 | 375,000 | 375,000 | 373,000 | 372,000 | 372,000 | 372,000 | 371,000 | 372,000 | 370,000 | 370,000 | 369,000 | 369,000 | 369,000 | 368,000 | 368,000 | 368,000 | 368,000 | 368,000 | 369,000 | 369,000 | 370,000 | 371,000 |
| additional paid-in capital | 911,089,000 | 902,124,000 | 875,864,000 | 855,973,000 | 820,337,000 | 790,418,000 | 764,273,000 | 746,606,000 | 721,543,000 | 715,052,000 | 700,684,000 | 680,057,000 | 653,657,000 | 636,321,000 | 616,429,000 | 583,851,000 | 534,411,000 | 514,299,000 | 481,004,000 | 448,679,000 | 420,536,000 | 381,632,000 | 362,534,000 | 334,112,000 | 316,797,000 | 297,748,000 | 283,854,000 | 274,584,000 | 246,568,000 | 226,469,000 | 214,697,000 | 184,213,000 | 172,144,000 | 168,960,000 | 166,603,000 | 163,306,000 | 161,850,000 | 150,308,000 | 147,004,000 | 142,658,000 | 140,390,000 | 136,613,000 | 134,895,000 | 134,118,000 | 133,827,000 | 132,291,000 | 131,851,000 | 131,417,000 | 130,517,000 | 129,653,000 | 129,312,000 |
| retained earnings | 1,066,049,000 | 1,196,385,000 | 1,286,699,000 | 1,341,175,000 | 1,325,247,000 | 1,297,688,000 | 1,261,376,000 | 1,327,572,000 | 1,309,461,000 | 1,246,612,000 | 1,199,976,000 | 1,162,515,000 | 1,122,921,000 | 1,132,807,000 | 1,145,641,000 | 1,119,337,000 | 1,085,461,000 | 1,088,788,000 | 1,104,762,000 | 1,073,362,000 | 1,057,470,000 | 1,012,713,000 | 1,038,783,000 | 931,358,000 | 931,934,000 | 927,773,000 | 895,205,000 | 905,139,000 | 876,931,000 | 847,310,000 | 839,564,000 | 774,734,000 | 756,926,000 | 738,538,000 | 724,586,000 | 713,851,000 | 699,466,000 | 665,714,000 | 653,279,000 | 637,923,000 | 617,722,000 | 604,102,000 | 587,725,000 | 572,186,000 | 550,120,000 | 535,805,000 | 520,448,000 | 505,834,000 | 487,524,000 | 479,551,000 | 472,730,000 |
| accumulated other comprehensive loss | -59,880,000 | -82,052,000 | -85,650,000 | -60,087,000 | -78,316,000 | -75,307,000 | -63,661,000 | -78,016,000 | -66,064,000 | -73,551,000 | -75,125,000 | -91,810,000 | -75,200,000 | -55,145,000 | -59,474,000 | -64,216,000 | -57,291,000 | -64,023,000 | -64,238,000 | -83,142,000 | -97,199,000 | -103,458,000 | -78,352,000 | -91,627,000 | -83,521,000 | -79,633,000 | -83,011,000 | -70,632,000 | -44,814,000 | -15,862,000 | -56,817,000 | -63,925,000 | -76,480,000 | -51,527,000 | -53,615,000 | -41,622,000 | -22,979,000 | -20,904,000 | -20,220,000 | -16,291,000 | |||||||||||
| total shareholders’ equity | 1,918,808,000 | 2,018,025,000 | 1,997,746,000 | 1,966,516,000 | 1,889,686,000 | 1,827,106,000 | 1,751,154,000 | 1,701,011,000 | 1,713,322,000 | 1,702,531,000 | 1,547,942,000 | 1,530,854,000 | 895,369,000 | 846,935,000 | 820,066,000 | 793,413,000 | 795,265,000 | 777,041,000 | 748,528,000 | 726,763,000 | 737,541,000 | 719,509,000 | 694,565,000 | 680,605,000 | 674,442,000 | 644,497,000 | 597,506,000 | 589,354,000 | 586,122,000 | ||||||||||||||||||||||
| total liabilities and shareholders’ equity | 2,557,868,000 | 2,644,259,000 | 2,670,424,000 | 2,736,017,000 | 2,703,867,000 | 2,721,170,000 | 2,730,753,000 | 2,755,360,000 | 2,638,692,000 | 2,599,696,000 | 2,363,401,000 | 2,350,721,000 | 2,294,805,000 | 2,299,892,000 | 2,304,846,000 | 2,270,187,000 | 2,262,957,000 | 2,084,642,000 | 2,067,866,000 | 2,053,096,000 | 2,027,589,000 | 1,999,022,000 | 1,998,415,000 | 1,925,028,000 | 1,884,410,000 | 1,872,618,000 | 1,844,832,000 | 1,872,198,000 | 1,593,202,000 | 1,617,808,000 | 1,555,422,000 | 1,121,924,000 | 1,133,453,000 | ||||||||||||||||||
| accounts receivables | 217,940,000 | 223,688,000 | 241,394,000 | 227,887,000 | 207,451,000 | 204,570,000 | 218,468,000 | 216,415,000 | 184,763,000 | 174,174,000 | 194,548,000 | 202,095,000 | 152,896,000 | 147,548,000 | 145,385,000 | 122,534,000 | 117,452,000 | 111,753,000 | 122,724,000 | 137,466,000 | 133,927,000 | 113,283,000 | 114,753,000 | 120,296,000 | 109,759,000 | 98,498,000 | 109,813,000 | 70,034,000 | |||||||||||||||||||||||
| bio-techne’s shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| total bio-techne’s shareholders’ equity | 2,078,492,000 | 2,138,650,000 | 2,068,850,000 | 2,014,375,000 | 1,963,559,000 | 1,997,746,000 | 1,966,516,000 | 1,889,686,000 | 1,827,106,000 | 1,751,154,000 | 1,701,770,000 | 1,714,376,000 | |||||||||||||||||||||||||||||||||||||||
| contingent consideration payable | 1,750,000 | 3,500,000 | 5,250,000 | 7,400,000 | 2,000,000 | 5,000,000 | 4,000,000 | 5,070,000 | 4,983,000 | 5,788,000 | 5,938,000 | 6,150,000 | 9,871,000 | 8,170,000 | 3,400,000 | 3,500,000 | 53,300,000 | 49,900,000 | 39,024,000 | 35,000,000 | |||||||||||||||||||||||||||||||
| current liabilities held-for-sale | 689,000 | 1,593,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| right of use asset | 102,277,000 | 98,326,000 | 97,976,000 | 83,937,000 | 69,745,000 | 65,556,000 | 63,450,000 | 64,293,000 | 71,396,000 | 73,834,000 | 71,830,000 | 68,154,000 | 70,018,000 | 71,465,000 | 73,751,000 | 75,824,000 | 76,962,000 | ||||||||||||||||||||||||||||||||||
| noncontrolling interest | -759,000 | -1,054,000 | -458,000 | 7,590,000 | 8,263,000 | 8,489,000 | 8,938,000 | ||||||||||||||||||||||||||||||||||||||||||||
| current portion of long-term debt obligations | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 | ||||||||||||||||||||||||||||||||||||
| long-term contingent consideration payable | 7,000,000 | 8,100,000 | 5,000,000 | 4,800,000 | 7,000,000 | 17,600,000 | 25,400,000 | 7,100,000 | 5,599,000 | 199,000 | 199,000 | 1,700,000 | 2,684,000 | 5,130,000 | 9,200,000 | 2,200,000 | 6,000,000 | 6,800,000 | 32,400,000 | ||||||||||||||||||||||||||||||||
| liabilities and shareholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| bio-techne's shareholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| total bio-techne’s shareholders' equity | 1,702,989,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| total bio-techne's shareholders' equity | 1,639,365,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| total shareholder's equity | 1,646,955,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| total bio-techne shareholders' equity | 1,562,971,000 | 1,539,453,000 | 1,521,916,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| total shareholders' equity | 1,571,234,000 | 1,439,285,000 | 1,381,192,000 | 1,291,268,000 | 1,323,348,000 | 1,174,224,000 | 1,165,589,000 | 1,146,266,000 | 1,096,425,000 | 1,109,469,000 | 1,079,061,000 | 1,058,292,000 | 997,819,000 | 852,962,000 | 856,343,000 | 837,947,000 | |||||||||||||||||||||||||||||||||||
| accounts receivable, net of 1,428 and 775 of reserves, respectively | 157,790,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, net of 1,526 and 775 of reserves, respectively | 128,243,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, net of 1,429 and 775 of reserves, respectively | 122,635,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of contingent consideration payable | 3,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term debt obligations, net of deferred financing costs of 360 and 0 respectively | 509,765,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| contingent portion of long-term debt obligations | 12,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term debt obligations, net of deferred financing costs of 388 and 0 respectively | 532,869,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term debt obligations, net of deferred financing costs of 402 and 0, respectively | 548,973,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, current | 7,067,000 | 4,484,000 | 5,218,000 | 3,139,000 | 3,839,000 | 3,491,000 | 2,545,000 | ||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses and other | 18,725,000 | 16,923,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 7,841,000 | 6,016,000 | 3,380,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses | 7,849,000 | 6,865,000 | 6,942,000 | 6,201,000 | 5,187,000 | 4,419,000 | 2,588,000 | 2,047,000 | 1,980,000 | 2,285,000 | 1,527,000 | 1,733,000 | 1,711,000 | 1,769,000 | 1,503,000 | 1,428,000 | 1,020,000 | 1,170,000 | 1,041,000 | ||||||||||||||||||||||||||||||||
| related party note payable, current | 3,733,000 | 3,808,000 | 3,789,000 | 3,868,000 | 4,024,000 | 3,004,000 | 5,949,000 | 5,949,000 | |||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 417 and 555, respectively | 87,156,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other receivables | 1,065,000 | 1,195,000 | 972,000 | 942,000 | 668,000 | 7,127,000 | 1,957,000 | 2,129,000 | 1,928,000 | 1,992,000 | 1,736,000 | 2,138,000 | 1,791,000 | 2,073,000 | 1,812,000 | 2,194,000 | 1,547,000 | 1,946,000 | |||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 549 and 555, respectively | 66,135,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 500 and 555, respectively | 70,915,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| available-for-sale investments | 0 | 3,575,000 | 3,575,000 | 151,357,000 | 162,590,000 | 138,477,000 | 132,376,000 | 135,765,000 | 128,569,000 | 131,713,000 | 143,966,000 | 145,129,000 | 148,114,000 | 148,949,000 | 131,988,000 | ||||||||||||||||||||||||||||||||||||
| investments in unconsolidated entities | 0 | 10,000,000 | 10,446,000 | 531,000 | 1,056,000 | 1,522,000 | 19,176,000 | 19,435,000 | 19,633,000 | ||||||||||||||||||||||||||||||||||||||||||
| related party note payable, long-term | 0 | 8,011,000 | 6,997,000 | 6,997,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | -30,593,000 | -5,388,000 | -3,909,000 | -9,953,000 | -14,321,000 | 14,553,000 | 12,837,000 | 10,250,000 | 12,141,000 | 21,775,000 | 6,877,000 | ||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 591 and 487, respectively | 65,885,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 492 and 487, respectively | 60,869,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 487 and 428, respectively | 47,874,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 488 and 428, respectively | 48,501,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 494 and 428, respectively | 38,306,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 467 and 428, respectively | 42,240,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 428 and 455, respectively | 38,183,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 473 and 455, respectively | 38,138,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 478 and 455, respectively | 32,187,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 458 and 455, respectively | 35,119,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 455 and 448, respectively | 35,668,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 451 and 448, respectively | 39,114,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| income taxes receivable | 3,816,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 450 and 448, respectively | 32,351,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 444 and 448, respectively | 34,092,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| trade accounts receivable, less allowance for doubtful accounts of 448 and 347, respectively | 35,914,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other accounts payable and accrued expenses | 2,688,000 |
We provide you with 20 years of balance sheets for Bio-Techne stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bio-Techne. Explore the full financial landscape of Bio-Techne stock with our expertly curated balance sheets.
The information provided in this report about Bio-Techne stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.